CORT

#1377
Corcept Therapeutics Inc.
44.2650 USD
+1.34%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
43.4700
44.3100
Jahresspanne
28.6601
89.0000
Tagesänderung
+1.34%
Monatliche Änderung
+36.79%
6 month change
-39.67%
Jahresänderung
-39.67%
Vorheriger Schlusskurs
43.6800
Eröffnung
43.5900
Bid
Ask
Tief
43.4700
High
44.3100
Volumen
175
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Nachrichten